|
PhytoCeutica Milestones
·
U.S. $5 million raised
·
Phytomics patent granted
in Australia
·
PHY906 patent allowed
in South Korea
·
NIH SBIR phase II grant
for “Genomic Bioresponse: Quality Control Botanical Drugs”
·
NCI SBIR phase I grant
or “Enhancement o Capecitabine by PHY906 in Liver Cancer”
·
PhytomicsQC licensed to
Sinphar Pharmaceuticals
·
Phytomics patent granted
in Singapore
·
PHY906 + capecitabine
phase I/II liver cancer study commenced
·
NCCAM SBIR phase I grant
for “LC/MS: A Molecular Fingerprint for Botanical Drugs”
·
NIH SBIR phaseI grant
or “Genomic Bioresponse: Quality Control for Botanical Drugs”
·
PHY906 + CPT-11/5-FU/LV
or PHY906 + CPT-11 phase I/II colorectal cancer study launched
·
PHY906 IND application
approved by FDA
·
U.S. $14 million raised
·
Seed round o over U.S.
$4 million raised
·
Development of PHY906
initiated
·
PhytoCeutica established |
|
PhytoCeutica,
Inc. 5 Science Park, Suite 13 New Haven,
CT 06511
Phone: 203-777-3462 Fax: 203-777-3538 E-mail: info@phytoceutica.com |
|
[Milestones] [
In The News] |
|
June June January October
September
June June November August
September
February
August August June March September
|
|
2005 2005 2005 2004
2004
2004 2004 2003 2003
2002
2002
2001 2000 1999 1999 1998
|
